ALDH1A1 and ovarian cancer: Although the prognostic role of ALDH1 is quite controversial, meta-analyses revealed that individuals with ovarian cancer who express more ALDH1 had lower overall and progression-free survival, poor prognosis, and clinicopathological characteristics [168,169].